Medicines safety

MHRA safety alerts and recalls

Every MHRA medicines recall, patient safety alert and Drug Safety Update, checked against GOV.UK every 2 hours from 07:00 to 19:00. Last checked 30 Oct, 17:00.

Pharmshark is not an official alerting route. Make sure your pharmacy receives alerts directly from the MHRA and through your organisation, and always act on the official GOV.UK notice.

Recalls needing action now

Class 1–3 recalls issued in the last 14 days and National Patient Safety Alerts issued in the last 30 days.

What do the recall classes mean?
ClassActionThe MHRA's definition
Class 1Immediate actionThe defect presents a risk of death or disability.
Class 2Action within 48 hoursThe defect may cause mistreatment or harm to the patient, but it is not life-threatening or serious.
Class 3Action within 5 daysThe defect is unlikely to cause harm to the patient.
Class 4Caution in useUsually minor defects in packaging or other printed materials.

A Class 1 recall usually comes with a National Patient Safety Alert. Source: MHRA, safety communications.

All alerts

51 items · page 1 of 3. Showing the community pharmacy view.

  1. RecallClass 2 · Action within 48 hours

    Class 2 Medicines Recall: Accord-UK Ltd, Lercanidipine Hydrochloride 10mg Film-Coated Tablets, EL(26)A/45

    Issued 29 Oct 2026 · EL(26)A/45 · Accord-UK Ltd

    Accord-UK Ltd is recalling one batch of Lercanidipine Hydrochloride 10mg Tablets due to a packaging mix-up involving the incorrect strength.

    GOV.UK notice Every medicines recall is shown.

  2. RecallClass 2 · Action within 48 hours

    Class 2 Medicines Recall: Advanz Pharma Limited, Mynzepli 40 mg/mL solution for injection in pre-filled syringe, EL(26)A/44

    Issued 29 Oct 2026 · EL(26)A/44 · Advanz Pharma Limited

    Advanz Pharma Limited are recalling specified batches of Mynzepli 40 mg/mL solution for injection in pre-filled syringe as a precautionary measure.

    GOV.UK notice Every medicines recall is shown.

  3. RecallClass 2 · Action within 48 hours

    Class 2 Medicines Recall: Xeal Pharma, Clopidogrel Oral Liquids (all strengths), EL(26)A/43

    Issued 26 Oct 2026 · EL(26)A/43 · Xeal Pharma

    Xeal Pharma have informed MHRA that all strengths of their Clopidogrel Oral Suspension and Clopidogrel Oral Solution products contain less than the labelled amount of clopidogrel.

    GOV.UK notice Every medicines recall is shown.

  4. RecallClass 2 · Action within 48 hours

    Class 2 Medicines Recall: Norgine Pharmaceuticals Limited, Pedmarqsi 80 mg/mL solution for infusion, EL(26)A/42

    Issued 12 Oct 2026 · EL(26)A/42 · Norgine Pharmaceuticals Limited

    Norgine Pharmaceuticals Limited is recalling the batches listed in the table due to risk of particulate matter being present in the product identified during routine stability investigations.

    GOV.UK notice Every medicines recall is shown.

  5. RecallClass 3 · Action within 5 days

    Class 3 Medicines Recall: Norgine Limited, MOVICOL Plain 13.7g powder for oral solution, EL(26)A/41

    Issued 5 Oct 2026 · EL(26)A/41 · Norgine Limited

    Norgine Limited is recalling specific batches of product as a precautionary measure due to some units containing the incorrect amounts of active ingredients.

    GOV.UK notice Every medicines recall is shown.

  6. RecallClass 4 · Caution in use

    Class 4 Medicines Defect Notification: B. Braun Melsungen AG, Meropenem 1000 mg powder and solvent for solution for infusion, EL(26)A/39

    Issued 23 Sep 2026 · EL(26)A/39 · B. Braun Melsungen AG

    B. Braun Melsungen AG has notified the MHRA that errors have been identified in the Patient Information Leaflet (PIL) included in some batches of Meropenem 1000 mg powder and solvent for solution for infusion.

    GOV.UK notice Every medicines recall is shown.

  7. RecallClass 4 · Caution in use

    Class 4 Medicines Defect Notification: Martindale Pharmaceuticals Ltd, Clobazam Martindale Pharma 5 mg/5 mL and 10 mg/5 mL Oral Suspension 150ml, EL(26)A/38

    Issued 17 Sep 2026 · EL(26)A/38 · Martindale Pharmaceuticals Ltd

    Martindale Pharmaceuticals has informed the MHRA of an error with the linear barcode of some batches of Clobazam 5mg/5mL and 10mg/5mL Oral Suspension 150mL.

    GOV.UK notice Every medicines recall is shown.

  8. RecallClass 2 · Action within 48 hours

    Class 2 Medicines Recall: Zentiva Pharma UK Limited, Fingolimod Zentiva 0.5 mg Capsules, EL(26)A/37

    Issued 20 Aug 2026 · EL(26)A/37 · Zentiva Pharma UK Limited

    Zentiva UK Pharma Limited are recalling one batch of Fingolimod Zentiva 0.5 mg Capsules (BN 4L01372H) as a precautionary measure due to a potential risk of contamination with metal particles.

    GOV.UK notice Every medicines recall is shown.

  9. RecallClass 4 · Caution in use

    Class 4 Medicines Defect Notification: Neuraxpharm UK Ltd, Tuzulby prolonged-release chewable tablets, EL(26)A/36

    Issued 23 Jul 2026 · EL(26)A/36 · Neuraxpharm UK Ltd.

    Neuraxpharm UK Ltd has informed the MHRA of missing safety information in the Patient Information Leaflet (PIL) and Summary of Product Characteristics (SmPC) for certain batches of Tuzulby prolonged release 20mg, 30mg and 40mg chewable tablets.

    GOV.UK notice Every medicines recall is shown.

  10. RecallClass 4 · Caution in use

    Class 4 Medicines Defect Notification: Macarthys Laboratories Ltd T/A Martindale Pharma, Xaggitin XL Prolonged-release Tablets, EL(26)A/35

    Issued 20 Jul 2026 · EL(26)A/35 · Macarthys Laboratories Ltd Trading as Martindale Pharma

    Macarthys Laboratories Ltd T/A Martindale Pharma has notified the MHRA of a manufacturing issue impacting several batches of Xaggitin XL Prolonged-release Tablets, due to the occurrence of incorrect tablet counts in the bottles.

    GOV.UK notice Every medicines recall is shown.

  11. RecallClass 2 · Action within 48 hours

    Class 2 Medicines Recall: Beckton Dickson UK Ltd, ChloraPrep 1mL applicator, EL(26)A/34

    Issued 13 Jul 2026 · EL(26)A/34 · Beckton Dickson UK Ltd

    Becton Dickinson UK Ltd are recalling batches of ChloraPrep 2% w/v / 70% v/v cutaneous solution 1mL applicators due to a potential breach of sterility in the packaging process.

    GOV.UK notice Every medicines recall is shown.

  12. RecallClass 2 · Action within 48 hours

    Class 2 Medicines Recall: Bristol Laboratories Limited, Phenoxymethylpenicillin 250 mg/5ml Sugar free Oral Solution BP, EL(26)A/33

    Issued 9 Jul 2026 · EL(26)A/33 · Bristol Laboratories Limited

    Bristol Laboratories Limited is recalling one batch (7124002) of Phenoxymethylpenicillin 250 mg/5 ml Oral Solution Sugar Free due to product labelling issues.

    GOV.UK notice Every medicines recall is shown.

  13. RecallClass 4 · Caution in use

    UPDATE: Class 4 Medicines Defect Notification: Relonchem Limited, Gabapentin Relonchem 50mg/ml Oral Solution, EL(26)A/31

    Issued 30 Jun 2026 · updated 7 Jul 2026 · EL(26)A/31 · Relonchem Limited

    Relonchem Limited have informed the MHRA that particles have been observed inside some bottles of Gabapentin Relonchem Oral Solution, identified through a customer complaint.

    GOV.UK notice Every medicines recall is shown.

  14. RecallClass 3 · Action within 5 days

    Class 3 Medicines Recall: Flamingo Pharma UK Ltd, Flucloxacillin Capsules BP 500mg, EL(26)A/32

    Issued 30 Jun 2026 · EL(26)A/32 · Flamingo Pharma UK Ltd

    Flamingo Pharma UK Ltd have informed the MHRA that certain packs of Flucloxacillin Capsules BP 500mg contain the incorrect PIL. The affected packs contain the PIL for Amoxicillin 500mg Capsules instead of the PIL for Flucloxacillin BP 500mg Capsules.

    GOV.UK notice Every medicines recall is shown.

  15. RecallClass 4 · Caution in use

    Class 4 Medicines Defect Notification: Brancaster Pharma Limited, Benzylpenicillin benzathine 1.2 Million I.U. and 2.4 Million I.U. powder for suspension for injection, EL(26)A/30

    Issued 29 Jun 2026 · EL(26)A/30 · Brancaster Pharma Limited

    Brancaster Pharma Limited has informed the MHRA that the Patient Information Leaflet (PIL) in the cartons for the batches listed in this notification were released with an outdated PIL.

    GOV.UK notice Every medicines recall is shown.

  16. RecallClass 3 · Action within 5 days

    Class 3 Medicines Recall: Orbit Pharma Limited, Cyclizine Lactate 50 mg/ml Solution for injection, EL(26)A/29

    Issued 16 Jun 2026 · EL(26)A/29 · Orbit Pharma Limited

    Orbit Pharma Limited is recalling a specific batch of Cyclizine Lactate 50 mg/ml Solution for injection as a precautionary measure due to Good Manufacturing Practice (GMP) deficiencies identified at the manufacturing site.

    GOV.UK notice Every medicines recall is shown.

  17. RecallClass 4 · Caution in use

    Class 4 Medicines Defect Notification: Cadila Pharmaceuticals Limited, Mirtazapine 30mg Tablets, EL(26)A/28

    Issued 8 Jun 2026 · EL(26)A/28 · Cadila Pharmaceuticals Limited, Dholka, India

    Cadila Pharmaceuticals Limited has informed the MHRA of an error with the European Article Number (EAN) barcode on the cartons of a batch of Mirtazapine 30mg Film-Coated Tablets distributed in Crescent Pharma Limited livery.

    GOV.UK notice Every medicines recall is shown.

  18. RecallClass 4 · Caution in use

    Class 4 Medicines Defect Notification: Teva UK Ltd, Ponlimsi (Denosumab) 60mg Solution for Injection in Pre-filled Syringe, EL(26)A/27

    Issued 4 Jun 2026 · EL(26)A/27 · Teva UK Ltd

    Teva UK Limited is reporting a labelling error on the carton for Ponlimsi (Denosumab) 60mg Solution for injection in Pre-filled Syringe. The carton states “For application to the skin” when the product is licensed for subcutaneous use.

    GOV.UK notice Every medicines recall is shown.

  19. RecallClass 2 · Action within 48 hours

    Class 2 Medicines Recall: Becton Dickinson UK Ltd, ChloraPrep 2% 1mL and ChloraPrep Frepp 2% 1.5mL applicators, EL(26)A/26

    Issued 2 Jun 2026 · EL(26)A/26 · Becton Dickinson UK Ltd

    Becton Dickinson UK Ltd are recalling batches of ChloraPrep 2% 1mL applicators and ChloraPrep Frepp 2% 1.5 mL applicators due to a potential breach of sterility in the packaging process.

    GOV.UK notice Every medicines recall is shown.

  20. RecallClass 2 · Action within 48 hours

    Class 2 Medicines Recall: Crescent Pharma Limited, Ramipril 2.5 mg Capsules, EL(26)A/25

    Issued 28 May 2026 · EL(26)A/25 · Crescent Pharma Limited.

    Crescent Pharma Limited is initiating a precautionary recall of one batch of Ramipril 2.5 mg Capsules following the identification of a potential packaging error at the manufacturing site.

    GOV.UK notice Every medicines recall is shown.

  21. RecallClass 4 · Caution in use

    Class 4 Medicines Defect Notification: Fresenius Medical Care Deutschland GmbH, balance 2.3% glucose, 1.25 mmol/l calcium, solution for peritoneal dialysis, EL(26)A/24

    Issued 14 May 2026 · EL(26)A/24 · Fresenius Medical Care Deutschland GmbH

    Fresenius Medical Care Deutschland GmbH have identified an error in the Braille printed on the outer label.

    GOV.UK notice Every medicines recall is shown.

  22. RecallClass 4 · Caution in use

    Class 4 Medicines Defect Notification: Milpharm Limited, Loperamide hydrochloride 2 mg Orodispersible Tablets, EL(26)A/23

    Issued 11 May 2026 · EL(26)A/23 · Milpharm Limited

    Milpharm Limited has identified a discrepancy in the Patient Information Leaflet (PIL) approved for Loperamide hydrochloride 2 mg Orodispersible Tablets.

    GOV.UK notice Every medicines recall is shown.

  23. RecallClass 2 · Action within 48 hours

    Class 2 Medicines Recall: Amarox Limited, Sertraline 100mg film-coated tablets, EL(26)A/22

    Issued 28 Apr 2026 · EL(26)A/22 · Amarox Limited

    Amarox Limited is recalling one batch of Sertraline 100 mg film-coated tablets as a precautionary measure due to an error at the manufacturing site.

    GOV.UK notice Every medicines recall is shown.

  24. RecallClass 3 · Action within 5 days

    Class 3 Medicines Recall: Omega Pharma Ltd, Napralief 250mg Gastro-Resistant Tablets, EL(26)A/21

    Issued 23 Apr 2026 · EL(26)A/21 · Omega Pharma Ltd

    Omega Pharma Ltd is recalling specific batches of Napralief 250mg Gastro-Resistant Tablets due to missing text in Section 2 and Section 3 of the Patient Information Leaflet (PIL) and on the Carton in packs of Napralief 250mg Gastro-resistant tablets.

    GOV.UK notice Every medicines recall is shown.

  25. RecallClass 4 · Caution in use

    Class 4 Medicines Defect Notification: Doncaster Pharma Limited, Hiprex 1g tablets, EL(26)A/20

    Issued 22 Apr 2026 · EL(26)A/20 · Doncaster Pharma Limited

    Doncaster Pharma Limited has informed the MHRA of an error related to the Braille embossing on the outer packaging of certain parallel imported batches of Hiprex 1 g tablets (POM).

    GOV.UK notice Every medicines recall is shown.

Source: the MHRA on GOV.UK. Contains public sector information licensed under the Open Government Licence v3.0. Pharmshark is not affiliated with or endorsed by the MHRA.